LitAlert ~~ GeneLit.com

    • Mutational spectrum of BRCA1/2 genes in Moroccan patients with hereditary breast and/or ovarian cancer, and review of BRCA mutations in the MENA region.
    • Elalaoui SC, Laarabi FZ, Afif L, Lyahyai J, Ratbi I, Jaouad IC, Doubaj Y, Sahli M, Ouhenach M, Sefiani A.
    • Breast Cancer Res Treat. 2022 May 17. doi: 10.1007/s10549-022-06622-3. Epub ahead of print.
    • A new tool is helping families conduct life-saving conversations about hereditary cancer.
    • Karavanov A.
    • FORCE. Blog. 2022 May 17.
    • Comparative efficacy and safety of poly (ADP-ribose) polymerase inhibitors in patients with ovarian cancer : a systematic review and network meta-analysis.
    • Luo J, Ou S, Wei H, Qin X, Jiang Q.
    • Front Oncol. 2022 May 17;12:815265. doi: 10.3389/fonc.2022.815265.
    • Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer.
    • Wen H, Feng Z, Ma Y, Liu R, Ou Q, Guo Q, Shen Y, Wu X, Shao Y, Bao H, Wu X.
    • BMC Cancer. 2022 May 16;22(1):550. doi: 10.1186/s12885-022-09602-4.
    • Dramatic response to local radiotherapy in a refractory metastatic mediastinal yolk sac tumor patient harboring a germline BRCA2 frameshift mutation: a case report.
    • Cheng X, Yu H, Li J, Han X, Meng E, Zhou H, Wang D, Niu B, Zhang X.
    • Cancer Biol Ther. 2022 Dec 31 [Published online: 2022 May 16];23(1):393-400. doi: 10.1080/15384047.2022.2072635.
    • Common Multiple Primary Cancers Associated with Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis,Treatment and Prognosis: A Review.
    • Ge S, Wang Z, Wang B, He J, Ma XX
    • Front Oncol. 2022 May 16;12:840431. doi: 10.3389/fonc.2022.840431.
    • Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review.
    • Dixon P, Keeney E, Taylor JC, Wordsworth S, Martin RM.
    • Genet Med. 2022 May 16:S1098-3600(22)00749-3. doi: 10.1016/j.gim.2022.04.020. Epub ahead of print.